π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The first part of this study is to find the recommended dosages of a combin...
Status
Terminated
Location
Royal United Hospital Bath NHS Trust
Start Date
2014-09
Trial ID
NCT02055690
Treatments Being Tested
This is a study evaluating the safety and effectiveness of Combretastatin A...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2005-03
Trial ID
NCT00113438
Treatments Being Tested
The purpose of the study is assess safety, bioactivity, and maximal tolerat...
Status
Completed
Location
Wilmer Eye Institute
Start Date
2003-05
Trial ID
NCT01570790
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and effi...
Status
Completed
Location
Southbay Oncology Hematology
Start Date
2008-03
Trial ID
NCT00653939
Treatments Being Tested
The purpose of the study is to determine the safety and efficacy of combret...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2007-08
Trial ID
NCT00507429
Treatments Being Tested
The primary objective of this study is to examine effects of fosbretabulin ...
Status
Completed
Location
OXiGENE Investigational Site
Start Date
2009-07
Trial ID
NCT01023295
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of th...
Status
Completed
Location
Mount Vernon Hospital
Start Date
2006-09
Trial ID
NCT00395434
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin and cisplatin, w...
Status
Terminated
Location
Josephine Ford Cancer Center at Henry Ford Hospital
Start Date
2003-11
Trial ID
NCT00077103
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Ireland Cancer Center
Start Date
1998-09
Trial ID
NCT00003768
Treatments Being Tested
Subjects achieving a clinical response in study OX4218s with a biomarker re...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2014-12
Trial ID
NCT02279602
Treatments Being Tested